ArticleCancer research2016

Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma.

Deepak Perumal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.